Company / Working Capital
Bone Biologics Corp Working Capital History
FY2017-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
-$547.6K
FY2019
5-year range
-$8.6M / -$166.3K
FY2017-FY2019
Trend
+93.6%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -$166,282 to -$547,620 over the past 2 years.
Based on SEC 10-K filings.
-$547,620 in FY2019.
Declined from -$166,282 to -$547,620 over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, working capital increased 93.6% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | - | - |
| FY2019 | -$547.6K | +93.6% |
| FY2018 | -$8.6M | -5070.9% |
| FY2017 | -$166.3K | - |
As of FY2019 · SEC 10-K · Updated Jun 28, 2026